基本資料
種類: ETF
費用比率%: 0.35
資產淨值: 192.81
成立日期: 20/12/2011
 
分析
市值分佈:
97.05%
大市值
--
中市值
--
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:58) 總持有投資項目: 25  
0%
 
100%
     10大 (72.45%)
代號 名稱 佔比% 持有日期
AMGNAmgen17.1428/02/2026
GILDGilead Sciences16.7128/02/2026
VRTXVertex Pharmaceuticals9.5828/02/2026
REGNRegeneron Pharmaceuticals7.5028/02/2026
SGEN5.0530/11/2023
ARGXargenx SE4.1228/02/2026
NTRANatera3.7228/02/2026
ALNYAlnylam Pharmaceuticals3.5528/02/2026
IQVIQVIA Holdings3.4528/02/2026
INSMInsmed Incorporated3.3928/02/2026
BIIBBiogen3.3028/02/2026
ONCBeOne Medicines Ltd3.1728/02/2026
MRNAModerna2.7628/02/2026
ILMNIllumina2.5628/02/2026
EXASExact Sciences Corp2.1528/02/2026
BNTXBioNTech SE American Depositary Share2.0228/02/2026
INCYIncyte Corp1.9228/02/2026
NBIXNeurocrine Biosciences1.7428/02/2026
ICLRICON plc1.4028/02/2026
QGENQiagen NV1.2828/02/2026
 1    2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.